AMD Polyclonal Antibody

This gene encodes a multifunctional protein. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme includes two domains with distinct catalytic activities, a peptidylglycine alpha-hydroxylating monooxygenase (PHM) domain and a peptidyl-alpha-hydroxyglycine alpha-amidating lyase (PAL) domain. These catalytic domains work sequentially to catalyze the conversion of neuroendocrine peptides to active alpha-amidated products. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

The AMD Polyclonal Antibody is a highly specific and reliable tool designed for the detection and quantification of AMD (Age-related Macular Degeneration) in various biological samples. This antibody is produced by immunizing animals with a specific antigen derived from AMD-related proteins, ensuring its exceptional sensitivity and specificity.

The AMD Polyclonal Antibody exhibits a strong affinity towards its target antigen, enabling accurate and precise detection of AMD biomarkers. It has been extensively validated through rigorous testing procedures, ensuring its consistent performance and reproducibility. This antibody is suitable for use in various applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA).

With its exceptional quality and reliability, the AMD Polyclonal Antibody offers researchers and clinicians a valuable tool for studying and diagnosing AMD. Its high specificity and sensitivity make it an ideal choice for both basic research and clinical applications. Furthermore, this antibody is manufactured under strict quality control standards, ensuring batch-to-batch consistency and minimizing any potential variability.

The AMD Polyclonal Antibody is supplied in a convenient and ready-to-use format, allowing for immediate application in the laboratory. It is provided in a liquid formulation, eliminating the need for reconstitution and ensuring optimal performance. Each vial contains a sufficient amount of antibody for multiple experiments, reducing the need for frequent reordering.

In summary, the AMD Polyclonal Antibody is a reliable and specific tool for the detection and quantification of AMD biomarkers. Its exceptional sensitivity, specificity, and convenience make it an invaluable asset for researchers and clinicians working in the field of AMD research and diagnosis.